Alectinib Completed Phase 1 / 2 Trials for Non-Squamous Non-Small Cell Lung Cancer / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs